C73 -Malignant neoplasm of thyroid gland
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C73 – N =18,836
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 10.2% | 18.1% | 12.2% | 7.9% | 51.6% | 254 |
1983 | 19.8% | 24.4% | 13.4% | 9.5% | 32.8% | 262 |
1984 | 20.9% | 28% | 15.5% | 7.5% | 28% | 239 |
1985 | 22.8% | 27.4% | 17.2% | 6.6% | 26.1% | 303 |
1986 | 26.6% | 24.5% | 11.9% | 10.4% | 26.6% | 278 |
1987 | 26.5% | 23% | 16% | 10.8% | 23.7% | 287 |
1988 | 23.6% | 22.8% | 18% | 11.6% | 24% | 267 |
1989 | 20.9% | 25.9% | 13.6% | 9.3% | 30.2% | 301 |
1990 | 16.7% | 27.9% | 17% | 11.2% | 27.2% | 294 |
1991 | 20.8% | 25.6% | 17.9% | 8.3% | 27.4% | 351 |
1992 | 19.7% | 29.9% | 12.4% | 10.8% | 27.1% | 314 |
1993 | 20.8% | 33% | 13.5% | 10.8% | 21.9% | 370 |
1994 | 25.1% | 27.9% | 14% | 14% | 19% | 358 |
1995 | 33.2% | 27.5% | 9.3% | 16.6% | 13.4% | 440 |
1996 | 34.7% | 26.5% | 8.8% | 14.2% | 15.7% | 452 |
1997 | 34.5% | 27.9% | 8.2% | 15.7% | 13.7% | 466 |
1998 | 32.1% | 25.8% | 12% | 12.9% | 17.2% | 458 |
1999 | 33.1% | 28.9% | 7.5% | 11.1% | 19.3% | 522 |
2000 | 34.8% | 27.6% | 10% | 10.2% | 17.5% | 561 |
2001 | 39.2% | 26.1% | 10.7% | 7.9% | 16.1% | 533 |
2002 | 37.4% | 26.5% | 10.7% | 9.6% | 15.8% | 551 |
2003 | 43.8% | 26.6% | 11.1% | 7.8% | 10.8% | 632 |
2004 | 45.2% | 22.3% | 12.5% | 7% | 13% | 754 |
2005 | 51.1% | 10.8% | 7.1% | 9% | 22% | 803 |
2006 | 49% | 10.6% | 9.5% | 8.2% | 22.7% | 780 |
2007 | 56.7% | 12% | 8% | 9.1% | 14.2% | 880 |
2008 | 65.7% | 8.9% | 8.1% | 8.2% | 9.2% | 881 |
2009 | 64.2% | 9.2% | 8.3% | 8.2% | 10.1% | 1,001 |
2010 | 63.2% | 8% | 9% | 9.4% | 10.5% | 1,005 |
2011 | 62.6% | 11.1% | 9.7% | 6.9% | 9.7% | 1,020 |
2012 | 66.8% | 9.3% | 6.8% | 8.9% | 8.3% | 1,036 |
2013 | 67.9% | 9.1% | 8.7% | 8.2% | 6.1% | 1,065 |
2014 | 71.5% | 8% | 8.3% | 5.2% | 7.1% | 1,118 |